Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer. (Q42882393)
Jump to navigation
Jump to search
scientific article published on 20 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer. |
scientific article published on 20 September 2010 |
Statements
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer (English)
Guy Jerusalem
Roberto Torres
Didier Verhoeven
José L Pedrini
Iya Smirnova
Mikhail R Lichinitser
Kelly Pendergrass
Sally Garnett
Francisco Sapunar
20 September 2010